The Chinese Nationalist Party (KMT) caucus yesterday said Academia Sinica President Wong Chi-huey (翁啟惠) should return to Taiwan immediately and explain his daughter’s holdings in OBI Pharma Inc (台灣浩鼎), while calling on premier-designate Lin Chuan (林全) to conduct background checks on future Cabinet members.
Wong has been accused of share price manipulation and conflict of interest over his endorsement of OBI Pharma after its shares tanked when it released discouraging clinic trial results and allegations that his daughter bought 3 million shares of the company from Ruentex Group (潤泰集團) chairman Samuel Yin (尹衍樑) in 2012.
Ruentex Group is a major shareholder of OBI Pharma.
Photo: Fang Pin-chao, Taipei Times
KMT Legislator Alicia Wang (王育敏) said the caucus had asked Academia Sinica for Wong’s itinerary, but the request was denied.
“Media reports said Wong went to Jerusalem to deliver a speech on March 14 and to San Diego [California] for another speech on March 17. Why is it that he is still abroad and cannot return until mid-April?” Wang asked.
“If it is Wong’s personal vacation, that would be fine, but if it is a public trip, it should be transparent to all,” Wang said, reiterating the caucus’ demand that Wong’s itinerary be made public.
Wang also raised questions about OBI Pharma’s shareholding structure.
“President-elect Tsai Ing-wen’s (蔡英文) brother and sister-in-law are also shareholders, and so is Wong’s daughter, Wong Yu-shioh (翁郁秀). Are others involved?” she asked, calling on Lin Chuan to make sure that his future Cabinet members are not involved.
KMT Legislator-at-large William Tseng (曾銘宗), who is also a former Financial Supervisory Commission chairman, denied that the KMT was making the accusations for political gain, as Yin has alleged.
Yin told the Chinese-language United Daily News on Wednesday that he bought back OBI Pharma shares in 2012 from US-based Optimer Pharmaceuticals Inc, the parent company of OBI Pharma at the time and which was in poor management, and then sold them, “without earning a penny on [his] part,” to other shareholders, including Wong Yu-shioh.
OBI Pharma did not make its Emerging Stock Market debut until 2014, Yin said, adding that it did not even have a reference price four years ago.
He said the company experienced its toughest time in 2012 and 2013, during which only he and the original shareholders cared about the company.
The company’s price might have increased thereafter, but it could have collapsed as well, Yin said.
Wong Chi-huey told the Chinese-language Economic Daily News yesterday that the statement issued by OBI Pharma chairman Michael Chang (張念慈) on Wednesday was correct, and that he would make an official announcement and straighten things out in the Legislative Yuan after he returns to the country.
Chang had issued a statement saying that Wong Yu-shioh was one of the major shareholders of Optimer Pharmaceuticals and bought OBI Pharma shares before its stock market debut.
Democratic Progressive Party (DPP) Legislator Huang Wei-cher (黃偉哲) also urged Wong Chi-huey to provide a public explanation.
“Wong Chi-huey should come out and clarify the incident, because things may get worse if he continues to stay away,” Huang said. “What his daughter does should not affect others in the business, because if the controversy surrounding OBI is not well taken cared of, it might affect the new government’s attitude toward the biotech industry.”
DPP legislators Chen Ting-fei (陳亭妃) and Tsai Shih-ying (蔡適應) added that it would be better for Wong Chi-huey to face the public, otherwise it might have a negative impact on Academic Sinica’s image.
Additional reporting by Loa Iok-sin
VITAL INDUSTRY: A war in the Strait would be a catastrophe, as Taiwan ‘lies at the heart’ of the world’s semiconductor industry, the magazine’s report said The government yesterday welcomed international attention on Taiwan’s security, saying that China is to blame for threatening regional stability, after a report by The Economist called Taiwan “the most dangerous place on Earth.” The report is featured on the cover of the magazine’s latest issue, which depicts the nation as the epicenter of a US-China rivalry. The cover shows Taiwan in a radar display with dots crossing the Taiwan Strait accompanied by a Chinese flag and dots nearing the east coast with a US flag. The US maintains a “one China” policy, while maintaining relations with Taiwan, but such “strategic ambiguity is breaking
HIGH-RISK GROUP: After the latest outbreak, family members of workers exposed to infection would from tomorrow be eligible for government-funded vaccines The Central Epidemic Command Center (CECC) yesterday reported four local COVID-19 cases: three family members of an infected worker at a quarantine hotel and a family member of an infected pilot. The new cases bring the number of infections involving China Airlines Ltd (中華航空) pilots and the Novotel Taipei Taoyuan International Airport hotel, where many of the airline’s crew members quarantined, to 24. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said three of them are the husband, son and daughter of case No. 1,129, a woman in her 60s, who works at the hotel. The son is in
NEXT STEP? The contract chipmaker said it would decide whether to add more plants based on operation efficiency, cost economics and demand Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is planning to build several more chipmaking fabs in the US state of Arizona beyond the one already planned, three people familiar with the matter said. TSMC, the world’s largest contract chipmaker, announced in May last year that it would build a US$12 billion fab in Arizona. The 12-inch wafer fab in Phoenix is expected to start mass production in 2024, the Investment Commission said in December, when it approved the plan. Three sources familiar with the matter, speaking on condition of anonymity as they were not authorized to speak to the media, said that up
VIRUS CURBS: Visiting people staying at healthcare and long-term care facilities in Taipei, New Taipei City and Taoyuan is banned until May 17, the CECC announced The Central Epidemic Command Center (CECC) yesterday banned visits to patients or residents at healthcare and long-term care facilities in three cities until May 17. It also reported six imported cases of COVID-19 and two cases with unclear infection sources. As the number of locally transmitted cases rises, some of whom have visited many places in Taipei, New Taipei City and Taoyuan, enhanced disease prevention measures have to be implemented in the three cities, said Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center. “Visiting people staying at healthcare and long-term care facilities in Taipei, New Taipei City and